Phase 1 Clinical Development Program

This webinar discusses smart processes to include in your Phase 1 clinical development program to save time and cost yet add value to your clinical asset. Cut time, not corners.

"*" indicates required fields

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

Comments

This field is for validation purposes and should be left unchanged.

Phase 1 Clinical Development Program

Resources to Consider

Phase 1 Study of OMN54 – Aneustat

Strategies and Solutions for Early Phase Formulation Development and...

A Competitive Ligand-binding Assay for the Detection of Neutralizing...

pTau217 Biomarker Assay

Human C14 AME (hAME) Services

16S rDNA Amplicon Sequencing of Mock Microbial Community Standards

Full Service Radiolabeled Human C14 AME (hAME) Studies

Method Validation of Quantitation IL-17A in Human Serum using the...

Determination of Fluticasone Propionate and Fluticasone...

Development of a Neutralizing Antibody Assay to support Clinical...

Clinical Services Overview

Alignment on Laboratory Support for Clinical Trials